Breakthrough research unveils retroelement-based aging biomarkers

Researchers at Weill Cornell Medicine and the epigenetics company TruDiagnostic have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.

CSL’s ‘big’ post-heart attack drug fails in Phase III trial

Share this article CSL’s AEGIS-II study for its MI drug CSL112 enrolled 18,200 participants across 850 sites worldwide. Image Credit: viewimage / Shutterstock. Australian CSL

February 12, 2024

Harmonic Health Launches Dementia Care Delivery Solution

What You Should Know: Harmonic Health, announced the launch of its comprehensive, evidence-based, dementia care model that bridges gaps in care by bringing together advanced

October 30, 2023

Research unveils how hormones affect immune system differences between genders

Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently.

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.